华森制药：上半年净利润5395.05万元，同比增长14.27%

Core Insights - The company reported a revenue of 442 million yuan for the first half of 2025, representing a year-on-year growth of 5.76% [1] - The net profit attributable to shareholders was 53.95 million yuan, showing a year-on-year increase of 14.27% [1] - The company plans to distribute a cash dividend of 0.35 yuan per 10 shares (tax included) to all shareholders, with no bonus shares issued [1]